Breast Cancer Treatment in Lucknow
Comprehensive Care at Lucknow Cancer Institute
Breast cancer is the most common cancer among women worldwide and in India. Early detection through screening dramatically improves outcomes, with cure rates exceeding 90% for stage I disease. Dr. Sidharth Pant provides complete breast cancer management including diagnosis, surgery coordination, chemotherapy, hormonal therapy and radiation planning.
Breast Cancer Statistics
Understanding the global and Indian burden of breast cancer
Global Burden
- Age‑standardized incidence rate (ASR): 46.3 per 100,000 women
- Female‑to‑male ratio: 100:1
- Peak incidence: 50–64 years
- Global 5‑year survival: 76.4%
- Highest incidence in developed countries
Indian Scenario
- ASR: 25.8 per 100,000 women
- Female‑to‑male ratio: 50:1 (higher male cases than global)
- Peak incidence: 40–59 years (younger than global average)
- India 5‑year survival: 66.1% (improving with early detection)
- Rising incidence in urban areas
Key Insights
- Most common cancer among Indian women
- Incidence rising by 1-2% annually
- Survival rates improving with early detection
- Urban incidence 2-3 times higher than rural
- Early detection can increase survival to >90%
Survival Comparison
Early detection dramatically improves survival rates
Who Is at Higher Risk?
Understanding breast cancer risk factors
Non‑Modifiable Risk Factors
- Family history (BRCA1/BRCA2 mutations)
- Genetic predisposition (TP53, PALB2, CHEK2 mutations)
- Age (risk increases with age)
- Dense breast tissue
- Personal history of breast cancer or certain biopsies
- Race/ethnicity (higher in Caucasian women)
Reproductive & Hormonal Factors
- Early menarche (<12 years)
- Late menopause (>55 years)
- Nulliparity (never pregnant)
- Late first pregnancy (>30 years)
- Hormone replacement therapy (prolonged use)
- Oral contraceptive use (long-term)
Lifestyle & Environmental Factors
- Obesity (post‑menopausal risk)
- Sedentary lifestyle
- Alcohol consumption
- Smoking
- Radiation exposure to chest (e.g., prior radiotherapy)
- Night shift work (circadian disruption)
Protective Factors
- Breastfeeding (longer duration better)
- Physical activity (regular exercise)
- Healthy weight maintenance
- Balanced diet rich in fruits and vegetables
- Limiting alcohol consumption
- Regular screening after age 40
Risk Assessment
Women with strong family history or multiple risk factors should consult a specialist for personalized risk assessment and screening recommendations. Genetic counseling may be recommended for high-risk individuals.
Screening & Early Detection
Regular screening saves lives - early detection improves survival to >90%
Screening Guidelines for Average Risk Women
Based on international and Indian guidelines
(discuss individual risk)
Screening Methods
Mammography
Gold standard for detecting early, non‑palpable cancers. Recommended every 2 years for women 50-74.
Clinical Breast Examination (CBE)
Performed by trained healthcare worker. Should be done annually for women 40+.
Breast Self‑Examination (BSE)
Monthly after age 20, for awareness. Not a substitute for clinical screening.
Breast Ultrasound
For dense breasts, young women, palpable lumps. Often used as adjunct to mammography.
High‑Risk Screening
Who Needs Enhanced Screening?
- BRCA mutation carriers
- Strong family history of breast/ovarian cancer
- Previous chest radiation therapy
- Certain genetic syndromes (Li-Fraumeni, etc.)
High-Risk Screening Protocol:
- Annual MRI + mammography starting age 30
- More frequent clinical exams (every 6 months)
- Consider risk-reducing medications/surgery
- Genetic counseling and testing
Warning Signs to Watch For
Early detection begins with awareness of symptoms
Common Breast Cancer Symptoms
Lump or Thickening
Most common sign - painless lump in breast or armpit
Size/Shape Change
Change in breast size, shape, or contour
Nipple Changes
Nipple retraction, inversion, or discharge (bloody/clear)
Skin Changes
Dimpling, puckering, orange peel appearance
Redness/Swelling
Redness, warmth, swelling (inflammatory breast cancer)
Persistent Pain
Uncommon for cancer, but persistent pain should be evaluated
Male Breast Cancer Symptoms
Lump Under Nipple
Painless lump beneath nipple area
Nipple Discharge
Clear or bloody nipple discharge
Skin Changes
Redness, scaling, or dimpling of nipple skin
Nipple Retraction
Nipple turning inward
Male breast cancer accounts for 1% of all breast cancers
Triple Assessment Protocol
Any breast lump requires comprehensive evaluation through triple assessment:
Clinical Examination
Detailed physical examination by breast specialist
Imaging
Mammogram and/or ultrasound based on age and breast density
Biopsy
Core needle biopsy or FNAC for definitive diagnosis
Important
Any new breast lump requires medical evaluation. Most lumps are benign, but only proper assessment can provide a definitive diagnosis.
Diagnosis & Staging
Comprehensive diagnostic work-up for accurate staging
Imaging Studies
Mammography
Craniocaudal + mediolateral oblique views. Gold standard screening method.
Breast Ultrasound
All ages, especially useful for dense breasts. Differentiates solid from cystic masses.
MRI Breast
High‑risk screening, staging, implant evaluation. Not for routine screening.
PET‑CT
For advanced stages to detect distant metastases.
Tissue Diagnosis & Molecular Testing
Fine Needle Aspiration Cytology (FNAC)
Initial assessment of palpable lumps. Quick but limited.
Core Needle Biopsy
Definitive diagnosis, provides tissue for receptor status.
Sentinel Lymph Node Biopsy
During surgery to assess lymph node involvement.
Molecular Testing
ER/PR/HER2 status, Ki‑67, Oncotype DX for personalized treatment.
Breast Cancer Staging & Survival
Survival rates are approximate and vary based on tumor biology, treatment response, and individual factors
Personalized Treatment Approach
Stage-based treatment strategies for optimal outcomes
Stage I‑II
Surgery Options:
- Breast conservation: Lumpectomy + radiation (preferred)
- Mastectomy: With or without reconstruction
- Sentinel lymph node biopsy: To assess spread
Adjuvant Therapy:
- Chemotherapy (if high risk features)
- Hormonal therapy (ER+ cancers)
- Trastuzumab (HER2+ cancers)
- Radiation (post‑lumpectomy)
Stage III
Treatment Sequence:
- Neoadjuvant chemotherapy: To shrink tumor first
- Surgery: After response assessment
- Radiation therapy: Post-surgery
- Systemic therapy: Continued based on response
Key Considerations:
- Multidisciplinary team approach
- Response-guided treatment
- Combination of local and systemic therapy
- Focus on complete pathological response
Stage IV
Treatment Approach:
- Systemic therapy first: Hormonal, chemo, targeted
- Local treatment: For palliation (pain, ulcer control)
- Quality of life: Primary focus
- Symptom management: Comprehensive support
Modern Advances:
- CDK4/6 inhibitors for HR+ cancers
- Immunotherapy for select cases
- Bone-targeted agents
- Personalized treatment based on biomarkers
Treatment Modalities
Chemotherapy Regimens
- AC‑T: Adriamycin, Cyclophosphamide, Taxane
- TC: Taxane + Cyclophosphamide
- CMF: Cyclophosphamide, Methotrexate, 5-FU
- Taxane-based: Weekly or 3-weekly schedules
Hormonal Therapy
- Tamoxifen: Pre/peri‑menopausal women
- Aromatase inhibitors: Post‑menopausal (Anastrozole, Letrozole)
- Ovarian suppression: + AI for younger women
- Fulvestrant: For advanced ER+ disease
Targeted Therapy
- Trastuzumab/Pertuzumab: HER2+ cancers
- CDK4/6 inhibitors: Palbociclib, Ribociclib (advanced HR+)
- PARP inhibitors: Olaparib for BRCA mutations
- mTOR inhibitors: Everolimus for resistant cases
Radiation Therapy
- Whole breast radiation: 40–50 Gy post‑lumpectomy
- Boost radiation: To tumor bed
- Regional nodal radiation: If high risk
- Palliative radiation: For symptom control
Survivorship & Follow‑up
Comprehensive care continues after treatment completion
Follow‑up Schedule
Every 3-6 months
- Clinical breast exam
- Symptom assessment
- Mammography annually
- Lab tests as needed
Every 6-12 months
- Clinical breast exam
- Annual mammography
- Health maintenance
- Survivorship counseling
Annually
- Annual mammography
- General health screening
- Long-term side effect monitoring
- Wellness counseling
Monitoring Includes:
- Clinical breast exam at each visit
- Mammography annually
- Tumour markers only if previously elevated
- Bone density monitoring (on hormonal therapy)
- Cardiac function monitoring (HER2 therapy)
- Thyroid function (if neck radiation)
Lifestyle & Support Services
Lifestyle Recommendations:
Regular Exercise
150 minutes moderate exercise/week
Weight Management
Maintain healthy BMI (18.5-24.9)
Balanced Diet
Mediterranean-style diet recommended
Avoid Harmful Habits
No smoking, limit alcohol
Support Services Available:
Breast Cancer in Special Groups
Tailored approaches for specific patient populations
Young Women (<40 years)
Unique Considerations:
- More aggressive tumor biology
- Higher likelihood of genetic mutations
- Fertility preservation important
- Psychosocial impact significant
Special Approaches:
- Genetic testing strongly recommended
- Fertility preservation before treatment
- More aggressive chemotherapy often needed
- Long-term follow-up for late effects
Pregnancy‑Associated Breast Cancer
Treatment Considerations:
- Surgery safe in all trimesters
- Chemotherapy safe after 1st trimester
- Radiation and hormonal therapy postponed until after delivery
- Multidisciplinary team with obstetrician
Key Points:
- Diagnosis often delayed due to pregnancy changes
- Prognosis similar to age-matched non-pregnant women
- Breastfeeding possible from unaffected breast
- Close monitoring of fetal well-being
Male Breast Cancer
Unique Aspects:
- Accounts for 1% of all breast cancers
- Often diagnosed at later stages
- Majority are ER+ (hormone sensitive)
- Higher rate of genetic mutations
Treatment Approach:
- Similar treatment principles as female breast cancer
- Genetic testing particularly important
- Mastectomy usually required due to small breast tissue
- Hormonal therapy (tamoxifen) mainstay for ER+
Recurrent Disease
Types of Recurrence:
- Local recurrence: In same breast/chest wall
- Regional recurrence: Lymph node areas
- Distant recurrence: Metastatic disease
Treatment Strategies:
- Local recurrence: Salvage surgery + radiation
- Distant recurrence: Systemic therapy based on receptor status
- Clinical trials for resistant disease
- Palliative care integration